Co-Diagnostics Inc. (CODX) Live Share Price, Invest From India

Co-Diagnostics Inc. Stock Performance

as on July 28, 2026 at 6:59 am IST

Day's Low
Day's High
$1.89
Day's Price Range
$2.14
$2.04
7.35%
Downside
4.90%
Upside
52 Week's Low
52 Week's High
$1.26
52-Week Price Range
$46.50
$2.04
38.24%
Downside
2179.41%
Upside

Co-Diagnostics Inc. share price movements today

Previous Close: $2.10
Open: $2.10
Volume: 584.6K
Day's Low - High: $1.89 - $2.14
52 Week Low - High: $1.26 - $46.50

Co-Diagnostics Inc. Historical Returns

1 Month Return: -31.37 %
3 Month Return: + 28.83 %
1 Year Return: -74.77 %
3 Year Return: -94.7 %
5 Year Return: -99.29 %

Co-Diagnostics Inc. Stock Fundamentals & Key Indicators

Check Co-Diagnostics Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$7.7M

EPS (TTM)

-13.5

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.31%

PE Ratio (TTM)

PEG Ratio

EBITDA

-30.9M

Revenue (TTM)

718.2K

Profit Margin

0.00%

Return On Equity TTM

-151.66%

Co-Diagnostics Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Co-Diagnostics Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Co-Diagnostics Inc.	SELL	$7.7M	-99.29%	NA	0.00%	NA
Stryker Corporation	BUY	$126.6B	22.92%	38.18	13.21%	1.08%
Edwards Lifesciences Corp	BUY	$47.6B	-24.92%	49.18	15.43%	NA
Medtronic plc	BUY	$106.5B	-36.25%	22.31	13.20%	3.46%
Abbott Laboratories	BUY	$179.5B	-14.49%	33.35	11.65%	2.46%

See all

Stock Returns calculator for Co-Diagnostics Inc. Stock including INR - Dollar returns

The Co-Diagnostics Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Co-Diagnostics Inc. investment value today

Current value as on today

₹27,122

Returns

-₹72,878

(-72.88%)

Returns from Co-Diagnostics Inc. Stock

-₹75,481 (-75.48%)

Dollar Impact

₹2,603 (+2.6%)

Analyst Recommendation on Co-Diagnostics Inc. Stock

Based on 6 analysts

SELL

0.00%

Buy

50.00%

Hold

50.00%

Sell

Based on 6 analysts, 50% of analysts recommend a 'SELL' rating for Co-Diagnostics Inc.. Average target price of $45

Co-Diagnostics Inc. Share Price Target

Get share price movements and forecasts by analysts on Co-Diagnostics Inc..

What analysts predicted

95.47%UPSIDE

Target Price

$45

Current Price

$2.04

Analyzed by

6 Analysts

Target

$45.00

Co-Diagnostics Inc. target price $45, a slight upside of 95.47% compared to current price of $2.04. According to 6 analysts rating.

Indian Investors' Interest in Co-Diagnostics Inc. Stock

Search interest for Co-Diagnostics Inc. Stock has decreased by -85% in the last 30 days, reflecting a downward trend in search activity.

Time period: June 28, 2026 to July 28, 2026

Change:-85% versus previous 30 day period

Co-Diagnostics Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Revenue	3	0	2	0	0	0	0	0	0	0
Gross Profit	0	0	2	0	0	0	0	0	0	0
Operating Income	-11	-10	-7	-10	-11	-8	-8	-7	-7	-9
EBITDA	-10	-8	-7	-9	-10	-7	-7	-6	-25	-8
Interest Expense	3	-	-	-	-	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-10	-9	-7	-9	-11	-7	-7	-7	-26	-9
Income Tax Expense	3	0	0	0	0	0	0	-1	0	0
Net Income	-14	-9	-7	-9	-11	-7	-7	-5	-25	-9
Net Profit Margin	-412.82%	-3684.36%	-286.03%	-1512.37%	-7387.37%	-14983.53%	-4745.02%	-4049.27%	-9755.05%	-6262.27%

Co-Diagnostics Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	0	0	0	74	97	34	6	3	0
Gross Profit	0	0	0	0	57	86	28	2	2	0
Operating Income	-1	-4	-6	-5	41	46	-26	-42	-40	-31
EBITDA	-1	-6	-6	-6	41	45	-10	-36	-36	-47
Interest Expense	0	0	0	0	0	0	14	-	-	-
Depreciation	-	0	0	0	0	0	1	1	1	1
Income Before Tax	-1	-6	-6	-6	42	45	-18	-38	-37	-48
Income Tax Expense	-	0	0	0	0	8	-4	-2	0	-1
Net Income	-1	-6	-6	-6	42	36	-14	-35	-37	-46
Net Profit Margin	0.00%	-90827.88%	-15714.27%	-2882.00%	56.98%	37.45%	-41.61%	-518.68%	-961.37%	-7533.62%

Co-Diagnostics Inc. Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Net Income	-9	-7	-9	-11	-7	-7	-5	-25	-9
Operating Cash Flow	-8	-5	-7	-8	-8	-8	-5	-6	-7
Investing Cash Flow	16	-4	4	0	7	17	2	0	0
Financing Cash Flow	-	-	-	0	0	0	4	6	4
Change in Cash	8	-9	-3	-7	-1	9	0	0	-3

Co-Diagnostics Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-6	-6	-6	42	36	-14	-35	-37	-46
Operating Cash Flow	-3	-4	-5	28	41	6	-22	-29	-29
Investing Cash Flow	0	0	0	-5	4	-58	15	17	26
Financing Cash Flow	5	1	5	19	0	-14	-1	0	11
Change in Cash	2	-2	0	42	45	-65	-8	-11	8

Global Institutional Holdings in Co-Diagnostics Inc.

Funds	Holdings
Triton Wealth Management, PLLC	0.03%
Wells Fargo & Co	0%
Heritage Wealth Advisors, LLC	0%
QRG Capital Management, Inc.	0.05%
Virtu Financial LLC	0.12%

See all

Co-Diagnostics Inc. News & Key Events

Insights on Co-Diagnostics Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, -25.74M → -9.14M (in $), with an average increase of 181.7% per quarter
NO EFFECT
Against Peers
In the last 3 years, Co-Diagnostics, Inc. Common Stock has experienced a drawdown of -94.7%, however Stryker Corporation resisted the overall trend and outperformed by 93.4%
NO EFFECT
Against Peers
In the last 1 year, Edwards Lifesciences Corp has given 5.3% return, outperforming this stock by 80.1%
NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 263.92K → 145.95K (in $), with an average decrease of 44.7% per quarter
NEGATIVE IMPACT
Price Dip
In the last 7 days, CODX stock has moved down by -11.0%

About Co-Diagnostics Inc.

Co-Diagnostics, Inc. operates as a molecular diagnostics company that develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers Co-Dx PCR platform, a polymerase chain reaction testing to patients in point-of-care and at-home setting. The company also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, malaria, dengue, human papillomavirus, chikungunya, and Zika virus. In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools for detection of infectious diseases; tests that identify genetic traits in plant and animal genomes; and portable diagnostic device designed to bring PCR to patients in point-of-care and at-home settings. Co-Diagnostics, Inc. was incorporated in 2013 and is based in Salt Lake City, Utah.

Organisation	Co-Diagnostics Inc.
Headquarters	2401 S. Foothill Drive, Salt Lake City, UT, United States, 84109
Industry	Medical Devices
CEO	Mr. Dwight H. Egan
E-voting on shares	Click here to vote

Key Management of Co-Diagnostics Inc.

Name	Title
Mr. David Nielsen	Chief Operating Officer
Mr. Dan Bohrer CPA	Vice President of Finance & Accounting
Mr. Christopher Thurston	Chief Technology Officer
Mr. Dwight H. Egan	Chairman, CEO & President
Mr. Richard David Abbott	President
Mr. Brian L. Brown CPA	CFO & Company Secretary

FAQs

What is Co-Diagnostics Inc. share price today?

Co-Diagnostics Inc. share price today is $2.04 as on July 28, 2026 at 1:29 am IST at the close of the market. Co-Diagnostics Inc. share today touched a day high of $2.14 and a low of $1.89.

What is the 52 week high and 52 week low for Co-Diagnostics Inc. share?

Co-Diagnostics Inc. share touched a 52 week high of $46.50 on January 1, 1970 and a 52 week low of $1.26 on January 1, 1970. Co-Diagnostics Inc. stock price today i.e. July 28, 2026 at 1:29 am IST is closed at $2.04,which is 95.61% down from its 52 week high and 61.90% up from its 52 week low.

What is Co-Diagnostics Inc.'s market capitalisation today?

Co-Diagnostics Inc. market capitalisation is $0.00T as on July 28, 2026 at 1:29 am IST.

How to invest in Co-Diagnostics Inc. Stock (CODX) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Co-Diagnostics Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Co-Diagnostics Inc. Shares that will get you 0.7353 shares as per Co-Diagnostics Inc. share price of $2.04 per share as on July 28, 2026 at 1:29 am IST.

What is the minimum amount required to buy Co-Diagnostics Inc. Stock (CODX) from India?

Indian investors can start investing in Co-Diagnostics Inc. (CODX) shares with as little as ₹95.9 or $1 (as of July 28, 2026 at 6:47 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹959.00 in Co-Diagnostics Inc. stock (as per the Rupee-Dollar exchange rate as on July 28, 2026 at 6:47 am IST). Based on Co-Diagnostics Inc. share’s latest price of $2.04 as on July 28, 2026 at 1:29 am IST, you will get 4.9020 shares of Co-Diagnostics Inc.. Learn more about fractional shares .

What are the returns that Co-Diagnostics Inc. has given to Indian investors in the last 5 years?

Co-Diagnostics Inc. stock has given -99.29% share price returns and 29.61% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?